SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SRF to set up Pharma Intermediates Plant at Dahej

27 Jan 2022 Evaluate

SRF’s board has approved project to create Pharma Intermediates Plant for undertaking precursor processes for production of Pharma products at Dahej at a cost of Rs 190 crore in order to tap new and upcoming business opportunities in the pharma space. The Board of Directors of the company at its meeting held on January 25, 2022 has approved the same.

SRF is a leader in refrigerants, engineering plastics and industrial yarns in India. The company also manufactures polyester films and fluoro specialties. Besides India, SRF has a presence in Dubai, South Africa and Thailand.

SRF Share Price

2780.75 8.85 (0.32%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4035.90
Tata Chemicals 782.10
SRF 2780.75
Pidilite Inds. 1476.15
Deepak Nitrite 1875.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×